4//SEC Filing
Riddell Alastair 4
Accession 0001415889-20-000740
CIK 0001604191other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:10 PM ET
Size
14.8 KB
Accession
0001415889-20-000740
Insider Transaction Report
Form 4
Riddell Alastair
Director
Transactions
- Award
Common Stock
2020-03-11$4.74/sh+770$3,650→ 100,770 total - Award
Common Stock
2020-03-11$3.99/sh+2,507$10,003→ 103,541 total - Award
Common Stock
2020-03-11$4.74/sh+264$1,251→ 101,034 total - Award
Common Stock
2020-03-11$3.63/sh+2,755$10,001→ 106,296 total - Award
Common Stock
2020-03-11$0.60/sh+14,584$8,750→ 123,635 total - Award
Common Stock
2020-03-11$1.04/sh+8,414$8,751→ 132,049 total
Footnotes (12)
- [F1]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2016.
- [F10]Based on the stock price at September 30, 2019, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.
- [F11]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2019.
- [F12]Based on the stock price at December 31, 2019 at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.
- [F2]Based on the stock price at September 30, 2016, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.
- [F3]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2016.
- [F4]Based on the stock price at December 31, 2016 at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.
- [F5]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors during 2016.
- [F6]Based on the stock price on April 21, 2017, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.
- [F7]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2017.
- [F8]Based on the stock price at December 31, 2017, at which time cash compensation would have otherwise been paid for service on the Issuer's Board of Directors.
- [F9]Shares issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2019.
Documents
Issuer
AzurRx BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001681349
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 4:10 PM ET
- Size
- 14.8 KB